1-4 of 4
Rei Watanabe
Close
Sort by
Journal Articles

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma

Clinical Trials & Observations
Alain H. Rook, Joel M. Gelfand, Maria Wysocka, Andrea B. Troxel, Bernice Benoit, Christian Surber, Rosalie Elenitsas, Marie A. Buchanan, Deborah S. Leahy, Rei Watanabe, Ilan R. Kirsch, Ellen J. Kim, Rachael A. Clark
Journal: Blood
Blood (2015) 126 (12): 1452–1461.
https://doi.org/10.1182/blood-2015-02-630335
Published: 2015
Includes: Supplemental data
Journal Articles

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

Brief Report
Filiberto Cedeno-Laurent, Rei Watanabe, Jessica E. Teague, Thomas S. Kupper, Rachael A. Clark, Charles J. Dimitroff
Journal: Blood
Blood (2012) 119 (15): 3534–3538.
https://doi.org/10.1182/blood-2011-12-396457
Published: 2012
Includes: Supplemental data
Journal Articles

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma

Rachael A. Clark, Jeffrey B. Shackelton, Rei Watanabe, Adam Calarese, Kei-ichi Yamanaka, James J. Campbell, Jessica E. Teague, Helen P. Kuo, DirkJan Hijnen, Thomas S. Kupper
Journal: Blood
Blood (2011) 117 (6): 1966–1976.
https://doi.org/10.1182/blood-2010-05-287664
Published: 2011
Includes: Supplemental data
Journal Articles

Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

Brief Report
James J. Campbell, Rachael A. Clark, Rei Watanabe, Thomas S. Kupper
Journal: Blood
Blood (2010) 116 (5): 767–771.
https://doi.org/10.1182/blood-2009-11-251926
Published: 2010